MicroStrategy
MSTR
Adobe
ADBE
Salesforce
CRM
Apple
AAPL
Meritage Homes
MTH
US Stock MarketDetailed Quotes
LYEL Lyell Immunopharma
- 0.613
- -0.028-4.41%
Close Dec 20 16:00 ET
- 0.613
- 0.0000.00%
Post 20:01 ET
179.01MMarket Cap-0.78P/E (TTM)
0.635High0.598Low2.81MVolume0.625Open0.641Pre Close1.72MTurnover1.30%Turnover RatioLossP/E (Static)292.16MShares3.25652wk High0.34P/B132.67MFloat Cap0.58252wk Low--Dividend TTM216.54MShs Float19.840Historical High--Div YieldTTM5.90%Amplitude0.582Historical Low0.614Avg Price1Lot Size
Lyell Immunopharma Stock Analyst Ratings & Price Target
Price Target
Updated: Dec 22, 2024
The average Lyell Immunopharma stock price target is 1.00 with a max estimate of 1.00 and a min estimate of 1.00
Review Lyell Immunopharma earnings estimates
Detailed Ratings
Receive timely notifications of rating changes
View more detailed ratings of institutions and analysts
View rating details page for historical data
Download APP
Analyst Ratings Disclaimer
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
Analysis
Price Target
Updated: Dec 22, 2024